SEC Form 4 · accession 0001140361-16-089118

MEDICINES CO /DE · MDCO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 6, 2016

Accepted (ET)

Dec 8, 2016 · 4:53 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001113481

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 6, 2016	P	337,680	$34.15	A	641,106	D
Common Stock^F2	Dec 7, 2016	P	172,764	$33.61	A	813,870	D
Common Stock^F3	Dec 7, 2016	P	86,587	$32.90	A	900,457	D
Common Stock^F4	Dec 8, 2016	P	19,188	$32.51	A	919,645	D
Common Stock^F5	Dec 8, 2016	P	5,501	$33.19	A	925,146	D
Common Stock^F6	holding	—	—		—	944,537	I	See footnote

No Table II lines on this filing.

F1Represents the weighted average purchase price of the shares purchased ranging from a low of $33.83 to a high of $34.80 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price for these transactions and the other transactions reported on this Form 4 and described in notes 2 through 5.
F2Represents the weighted average purchase price of the shares purchased ranging from a low of $33.29 to a high of $34.27 per share.
F3Represents the weighted average purchase price of the shares purchased ranging from a low of $32.29 to a high of $33.28 per share.
F4Represents the weighted average purchase price of the shares purchased ranging from a low of $32.07 to a high of $33.06 per share.
F5Represents the weighted average purchase price of the shares purchased ranging from a low of $33.07 to a high of $33.25 per share.
F6These shares of the issuer's common stock are owned by Eshelman Ventures, LLC, an entity wholly owned by the reporting person.